How Sleep Apnea and Obesity May Quietly Fuel Cancer Growth
A new perspective in the International Journal of Obesity argues that obesity, obstructive sleep apnea, and cancer form an interconnected ...
A new perspective in the International Journal of Obesity argues that obesity, obstructive sleep apnea, and cancer form an interconnected ...
The first controlled study of GLP-1 receptor agonists and nail health, presented at the EADV Congress 2026, found nail detachment ...
A network meta-analysis of 43 studies and over 930,000 patients finds bariatric surgery reduces major cardiovascular events, heart failure and ...
A nationwide Swedish cohort study of 171,917 people with type 2 diabetes found GLP-1 receptor agonists were associated with roughly ...
A post hoc analysis of the SCHOLAR study found that over 42 percent of Chinese adults starting semaglutide also took ...
A new review in Diabetes Therapy finds that three amylin-based agonists—zenagamtide, eloralintide and CagriSema—deliver unprecedented weight loss and, in some ...
A new online study shows that asking GLP-1RA users to photograph their medications is feasible and reveals that most compounded ...
A new review maps how the gut hormones behind blockbuster weight-loss drugs may also influence PCOS, endometriosis and gynaecological cancers.
As powerful new weight-loss drugs transform obesity treatment, leading surgeons argue that metabolic bariatric surgery remains an essential, durable component ...
A new EASO position statement argues that Europe's health systems must be restructured around five pillars to deliver the benefits ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine